Montelukast Prescribing at ROYAL PRIMARY CARE CLAY CROSS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,799
Total Quantity
44.8K
NHS Cost
£2.2K
vs National Avg
+162.7%
ROYAL PRIMARY CARE CLAY CROSS prescribed 1,799 items of Montelukast over the last 12 months at a cost of £2,212 to the NHS. This is 162.7% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
151
Jul 2026
144
Jul 2026
158
Jul 2026
134
Jul 2026
147
Jul 2026
140
Jul 2026
147
Jul 2026
167
Jul 2026
163
Jul 2026
135
Jul 2026
153
Jul 2026
160
Prescribing Details
| Total Items | 1,799 |
|---|---|
| Total Quantity | 44,818 |
| Total NHS Cost | £2,212 |
| Presentations | 4 different forms |
| vs National Average | +162.7% |
Montelukast Prescribing Comparison
| This practice | 1,799 items |
|---|---|
| National average per practice | 685 items |
| Difference | +162.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.